Mónica Millán-Jiménez
Mónica Millán-Jiménez
Universidad de Sevilla, Departamento de Farmacia y Tecnología Farmacéutica
Verified email at us.es
Title
Cited by
Cited by
Year
Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery
A Miranda, M Millán, I Caraballo
International journal of pharmaceutics 311 (1-2), 75-81, 2006
852006
Relationship between drug percolation threshold and particle size in matrix tablets
I Caraballo, M Millan, AM Rabasco
Pharmaceutical research 13 (3), 387-390, 1996
851996
The role of the drug/excipient particle size ratio in the percolation model for tablets
M Millán, I Caraballo, AM Rabasco
Pharmaceutical research 15 (2), 216-220, 1998
681998
Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets
I Fuertes, A Miranda, M Millán, I Caraballo
European journal of pharmaceutics and biopharmaceutics 64 (3), 336-342, 2006
592006
Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets
A Miranda, M Millán, I Caraballo
Journal of pharmaceutical sciences 96 (10), 2746-2756, 2007
552007
Percolation thresholds in ultrasound compacted tablets
I Caraballo, M Millán, A Fini, L Rodriguez, C Cavallari
Journal of controlled release 69 (3), 345-355, 2000
412000
Study of critical points of drugs with different solubilities in hydrophilic matrices
I Fuertes, I Caraballo, A Miranda, M Millán
International journal of pharmaceutics 383 (1-2), 138-146, 2010
362010
Study of percolation thresholds in ternary tablets
I Caraballo, M Fernandez-Arevalo, M Millán, AM Rabasco, ...
International journal of pharmaceutics 139 (1-2), 177-186, 1996
301996
Study of the critical points in lobenzarit disodium hydrophilic matrices for controlled drug delivery
A Miranda, M MillÁn, I Caraballo
Chemical and pharmaceutical bulletin 54 (5), 598-602, 2006
262006
Study of morphine hydrochloride percolation threshold in Eudragit® RS–PM matrices
LM Melgoza, I Caraballo, J Alvarez-Fuentes, M Millán, AM Rabasco
International journal of pharmaceutics 170 (2), 169-177, 1998
251998
Zero-order release periods in inert matrices. Influence of the distance to the percolation threshold
I Caraballo, M Millán, AM Rabasco, H Leuenberger
Pharmaceutica Acta Helvetiae 71 (5), 335-339, 1996
221996
Validation study of the conductometrical analysis. Application to the drug release studies from controlled release systems.
I Caraballo, J Alvarez-Fuentes, LM Melgoza, M Millán, MA Holgado, ...
Journal of pharmaceutical and biomedical analysis 18 (1-2), 281, 1998
201998
Influence of two different types of excipient on drug percolation threshold
MC Soriano, I Caraballo, M Millan, RT Pinero, LM Melgoza, AM Rabasco
International journal of pharmaceutics 174 (1-2), 63-69, 1998
181998
Superdisintegrants in tablet formulations
I Caraballo, M Fernandez-Arevalo, M Millan
Drug Dev Ind Pharm 23, 665-669, 1997
171997
Stability study of flutamide in solid state and in aqueous solution
A Miranda, I Caraballo, M Millan
Drug development and industrial pharmacy 28 (4), 413-422, 2002
142002
Effect of drug particle size in ultrasound compacted tablets: continuum percolation model approach
M Millán, I Caraballo
International journal of pharmaceutics 310 (1-2), 168-174, 2006
122006
Application of a new mathematical method for the estimation of the mean surface area to calculate the percolation threshold of lobenzarit dissodium salt in controlled release …
A Boza, R Blanquero, M Millan, I Caraballo
Chemical and pharmaceutical bulletin 52 (7), 797-801, 2004
82004
Application of percolation theory to characterize the release behavior of carteolol matrix systems
I Caraballo, MA Holgado, M Fernández-Arévalo, M Millán, AM Rabasco
Drug development and industrial pharmacy 23 (1), 1-8, 1997
81997
Study of the critical points in the release and hydration kinetics of swellable matrix type controlled delivery systems
A Miranda, M Millán, I Caraballo
Int J Pharm 311 (1), 75-81, 2006
62006
Optimisation of a complexation process as a new method for obtaining a controlled morphine delivery system
M Fernández-Arévalo, I Caraballo, M Millán, MA Holgado, ...
STP pharma sciences 12 (5), 334-336, 2002
62002
The system can't perform the operation now. Try again later.
Articles 1–20